NCT04206618View on ClinicalTrials.gov

Circulating Myokine Levels and Bone Metabolism

CompletedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

September 30, 2020

Study Completion Date

November 10, 2020

Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG

Teriparatide

1 subcutaneous injection daily for 12 months

DRUG

Denosumab

1 subcutaneous injection every 6 months for 12 months

Trial Locations (1)

56429

424 General Military Hospital, Thessaloniki

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

424 General Military Hospital

OTHER

NCT04206618 - Circulating Myokine Levels and Bone Metabolism | Biotech Hunter | Biotech Hunter